Member Info for Shukan

“HemoGenyx have been working with a new type of 'humanised mice' in these trials and have made a Patent application. These mice allow researchers to test and develop drugs in a much more efficient and fast way, in a live animal on a 'human background' using human cells which live inside that animal.” 0:5.25 into the video Dr Vladislav explains the hopes and research to other larger players of the patented mice at some point in the future - and indeed in talks but without disclosure

0:4.32 into the video question was asked “how important is the huminised mice patent?

HemoGenyx seeks to address the problems faced by tens of thousands of blood cancer patients that arise with Bone Marrow (BM) and Hematopoietic Stem Cell (HSC) Transplants, with their revolutionary treatments and therapies. Broad range of adverse side effects associated with current methods of conditioning patients for BM/HSC transplants – preventing many patients from receiving such treatment.

BRB1 - unfortunately for him , a shareholder on the ball

The market is indeed watching any sniff of the JV will send the SP into positive territory, we have the usual expected profit taking -now into week three from the ground breaking news from the Lab , we will see profit takers taking their positions, interesting to see that the company hopes to generate revenues from their patented mouse models in the future , and indeed talks with bio techs in the near future , this means huminised blood , human AML cells living within the mouse model , next step is infusion of CDX antibodies, very exciting times ahead for Hemogenyx- the market will catch up of course in the meantime buying at this level seems a very good idea.

Here it is in all it’s glory the question and the answer PATENT : https://www.youtube.com/watch?v=3z6IKgPik0s

0:4.32 into the video question was asked “how important is the huminised mice patent?” It all there folks answer from Dr Vladislav, I have said nothing different just repeating what I hear with my ears as you will as well .

YTSS - any JV will require extra funding for sure , at the moment they are fine I have tweeted the company’s position under the #hemo

I must add indeed my Aunt suffered AML and subsequently died, I too also have prostate cancer , so you can imagine I have a total dedication to research on cancers with reasonable working knowledge of cancer cell receptors their meaning and how different drugs interact with such receptors, now all we can do is report his post and email the admin here that this guy is blatantly here to demoralise a very nasty individual indeed that is very obvious from his posts here - don’t be taken in that he is offering another opinion- the guy is evil and with cancer patients world wide hoping a company like Hemogenyx can help them at some point in the future this idiot should be fully ashamed of himself and quite disgusting personal remarks to me prove my point .

my name I should of said

Daveavt DAVEVT (Domestos Dave) in spot no 43 PYC HEMO out of 100 LOL you cant make this stuff up LOL Cant find name any where on that list -

I have this idiot filtered , so can not read his garbage I advice others to do many on the other two boards have the same opinion as us here so we are not alone in this fact.

https://en.wikipedia.org/wiki/H._Michael_Shepard

Dr. Shepard built successful programmes at various biotechnology companies. He helped launch Canji, Inc., the first company to successfully traverse the gene therapy regulatory framework to initiate a clinical trial with adenovirus-p53, a disabled adenovirus encoding the p53 tumor suppressor gene, for drug-resistant ovarian cancer. Shepard helped to engineer Canji's relationship with Schering-Plough, which acquired Canji. Likewise, Shepard was the founder, president and CSO of Receptor BioLogix, which focused on developing protein therapies to treat cancer, autoimmune, metabolic and other diseases, and was acquired by Symphogen. NewBiotics, Inc., which Shepard also founded, invented a new class of therapeutics, called Enzyme Catalyzed Therapeutic Agents. That company was acquired by Kiadis Pharma.

Dr. Shepard, said: "Hemogenyx is developing cancer therapies that have the potential to save lives, and I'm proud to be a part of that. As a member of Hemogenyx's Scientific Advisory Board, I'll be able to use the experience I've accrued working with other pre-clinical biotechnology programmes to help guide Hemogenyx toward the release of successful antibody-based therapies."� His work has led to the discovery and development of many successful cancer treatments including Herceptin/trastuzumab, an antibody used to treat breast cancer patients. Advisory to Hemogenyx on the pre-clinical and clinical development of its lead candidate CDX antibodies. These highly specific CDX antibodies selectively eliminate hematopoietic stem cells and progenitors and a subset of acute myelogenous leukemia (AML), and promise to offer safer alternatives to chemotherapy and radiation as means of eliminating refractory/relapsed AML and patient conditioning before bone marrow transplants.

Dr Vladislav puts to bed all the arguments, presented here by Domestos Dave, I would respectfully suggest that listening to the interview a couple of times , compairing that to the sharecast post below should give you an understanding of DD agenda here and note an unqualified one at that , as a shareholder the good Dr is not out to missrepresent the facts but he is pointing out facts of their current research , and as they say all on track, as pointed out before, the appointment of Dr Shepherd with those credentials can only be a positive moving forward , I have also posted the cash position of the company on my Twitter feed , this also puts to bed the lies on placing. Of course due diligence required by potential investors, I believe most sensible investors have made their minds up and are waiting for entry at the right price. We await further news on a JV partner, their patented humanised mouse models, the CDX - antibodies replicating earlier ground breaking results the company now in the driving seat to create a new and less toxic way of helping those patients cancer patients with AML , for this the company should be applauded not demonised as we have here on certain posts by a certain individual with no insight into the company whatsoever, for this reason alone it is worth a filter on his name , many have posted he is -that also should be applauded. For me I will be adding a further sizeable chunk the sp an opportunity to do so - looking forward to further developments .

https://www.youtube.com/watch?v=3z6IKgPik0s

‪ https://www.youtube.com/watch?v=3z6IKgPik0s‬

Yes it’s on permanently this time , we may see 2.5 next week let’s see - buying zone again for many including me another decent chunk

Yes - absolutely dedicated and on the right path to fighting this dreadful disease, also there is a two pronged approach to the research coming out of the lab